1Cell.Ai Named Best Healthtech Startup 2026

Recognised for Innovation in Precision Oncology & Patient Impact

x

    Request a Callback

    Fill in your details and our team will get in touch with you.


    FAQ’s

    CTC Testing

    Circulating tumor cell testing — its clinical role and how it complements ctDNA in precision oncology.

    All
    Clinicians
    Patients
    Cost, TAT & Logistics
    CTC Testing
    Interpreting Reports
    Liquid Biopsy & ctDNA
    NGS for Oncologists
    Tissue NGS
    Back to FAQ's
    01 What is the clinical role of CTC testing in oncology? Patients

    Circulating tumor cells (CTCs) are intact tumor cells shed into the bloodstream, and testing them supports prognosis, longitudinal monitoring of treatment response, and early detection of relapse. Because CTCs are whole cells, they can provide DNA, RNA, and protein-level information that fragment-based ctDNA analysis alone cannot capture.

    No results found!

    Still have questions?

    Need help understanding your report?

    Our oncology support team can help clinicians and patients navigate precision oncology insights — from sample logistics to interpreting actionable variants.

    NABL & CAP accredited lab · Pune, India · 1800 123 12355

    1Cell.Ai
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.